Translational Hurdles in Stroke Recovery Studies
- 22 March 2016
- journal article
- review article
- Published by Springer Nature in Translational Stroke Research
- Vol. 7 (4) , 331-342
Abstract
Emerging understanding of brain plasticity has opened new avenues for the treatment of stroke. The promising preclinical evidence with neuroprotective drugs has not been confirmed in clinical trials, thus nowadays, researchers, pharmaceutical companies, and funding bodies hesitate to initiate these expensive trials with restorative therapies. Since many of the previous failures can be traced to low study quality, a number of guidelines such as STAIR and STEPS were introduced to rectify these shortcomings. However, these guidelines stem from the study design for neuroprotective drugs and one may question whether they are appropriate for restorative approaches, which rely heavily on behavioral testing. Most of the recovery studies conducted in stroke patients have been small-scale, proof-of-concept trials. Consequently, the overall effect sizes of pooled phase II trials have proved unreliable and unstable in most meta-analyses. Although the methodological quality of trials in humans is improving, most studies still suffer from methodological flaws and do not meet even the minimum of evidence-based standards for reporting randomized controlled trials. The power problem of most phase II trials is mostly attributable to a lack of proper stratification with robust prognostic factors at baseline as well as the incorrect assumption that all patients will exhibit the same proportional amount of spontaneous neurological recovery poststroke. In addition, most trials suffer from insufficient treatment contrasts between the experimental and control arm and the outcomes have not been sufficiently responsive to detect small but clinically relevant changes in neurological impairments and activities. This narrative review describes the main factors that bias recovery studies, both in experimental animals and stroke patients.Keywords
This publication has 107 references indexed in Scilit:
- RIGOR Guidelines: Escalating STAIR and STEPS for Effective Translational ResearchTranslational Stroke Research, 2012
- Effects of circuit training as alternative to usual physiotherapy after stroke: randomised controlled trialBMJ, 2012
- The economic cost of brain disorders in EuropeEuropean Journal of Neurology, 2011
- Adverse Effects of Bone Marrow Stromal Cell Treatment of Stroke in Diabetic RatsStroke, 2011
- Body-Weight–Supported Treadmill Rehabilitation after StrokeNew England Journal of Medicine, 2011
- Prediction of Motor Recovery Using Initial Impairment and fMRI 48 h PoststrokeCerebral Cortex, 2011
- Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trialThe Lancet Neurology, 2011
- The EXCITE Stroke TrialStroke, 2010
- Effects of Robot-Assisted Therapy on Upper Limb Recovery After Stroke: A Systematic ReviewNeurorehabilitation and Neural Repair, 2007
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006